Skip to content
Disclosery

Phase 2 Partners, LLC: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Phase 2 Partners, LLC on CME, newest first. How the timeline and the estimate are built.

Phase 2 Partners, LLC held 0 CME shares at 2024-12-31 per its 13F-HR filed 2025-02-14.

the latest 13F is the newest step

  1. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -25,756 shares

    13F-HR 0001214659-25-002843 filed by Phase 2 Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-09-30
    13F 25,756 shares
    Change vs previous 13F +25,756 shares

    3.36% of the 13F portfolio, value $5,683,061.

    13F-HR 0001214659-24-019141 filed by Phase 2 Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-09-30
    13F 0 shares
    Change vs previous 13F -1,765 shares

    13F-HR 0001214659-23-015165 filed by Phase 2 Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2023-06-30
    13F 1,765 shares
    Change vs previous 13F -102,395 shares

    0.15% of the 13F portfolio, value $327,037.

    13F-HR 0001214659-23-011284 filed by Phase 2 Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2023-03-31
    13F 104,160 shares
    Change vs previous 13F not available

    8.6% of the 13F portfolio, value $19,948,723.

    13F-HR 0001214659-23-007184 filed by Phase 2 Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).